ADMA Biologics Inc - Common Stock (NQ:ADMA)

9.025 +0.075 (+0.84%)

Streaming Delayed Price Updated: 3:40 PM EDT, Jul 6, 2026 Add to My Watchlist

Price and Volume

Volume	1,806,587
Open	8.915
Bid (Size)	9.020 (1,100)
Ask (Size)	9.030 (1,500)
Prev. Close	8.950
Today's Range	8.840 - 9.100
52wk Range	7.210 - 20.46
Shares Outstanding	196,357,149
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Today 13:28 EDT

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 6, 2026) - Kahn Swick & Foti, LLC ("KSF")...

Via Newsfile

ADMA CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

July 05, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Performance

YTD	-49.5%	-49.5%
1 Month	+13.2%	+13.2%
3 Month	-2.7%	-2.7%
6 Month	-49.9%	-49.9%
1 Year	-49.5%	-49.5%

More News

ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

July 05, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

ADMA Biologics, Inc. (ADMA) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit

July 04, 2026

Via NewMediaWire

ADMA Biologics, Inc. (ADMA) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit

July 04, 2026

Via TheNewswire.com

ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Deadline in Securities Fraud Class Action Lawsuit

July 03, 2026

Via TheNewswire.com

ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Deadline in Securities Fraud Class Action Lawsuit

July 03, 2026

Via NewMediaWire

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

July 03, 2026

From Schall Law

Via GlobeNewswire

ADMA INVESTOR REMINDER: ADMA Biologics, Inc. Investors Have Until August 10, 2026 To Seek Lead Plaintiff Role

July 02, 2026

From Kirby McInerney LLP

Via Business Wire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 02, 2026

Via Newsfile

ADMA Biologics, Inc. (ADMA) Securities Fraud Class Action Lawsuit Filed; August 10, 2026, Lead Plaintiff Deadline

July 02, 2026

Via NewMediaWire

ADMA Biologics, Inc. (ADMA) Securities Fraud Class Action Lawsuit Filed; August 10, 2026, Lead Plaintiff Deadline

July 02, 2026

Via TheNewswire.com

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 01, 2026

Via Newsfile

ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

July 01, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

June 30, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA

June 30, 2026

From Pomerantz LLP

Via GlobeNewswire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

June 30, 2026

Via Newsfile

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

June 30, 2026

From Schall Law

Via GlobeNewswire

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

June 30, 2026

From Lowey Dannenberg, P.C.

Via GlobeNewswire

ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP

June 29, 2026

Via NewMediaWire

ADMA Biologics, Inc. (ADMA) Investors: August 10, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP

June 29, 2026

Via TheNewswire.com

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

June 29, 2026

Via Newsfile

ADMA BIOLOGICS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates ADMA Biologics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – ADMA

June 29, 2026

From Scott+Scott Attorneys at Law LLP

Via Business Wire

Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗

June 29, 2026

Via The Motley Fool

ADMA Biologics, Inc. (ADMA) Class Action Lawsuit Seeks Recovery for Investors; August 10, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP

June 28, 2026

Via TheNewswire.com

Frequently Asked Questions

Is ADMA Biologics Inc - Common Stock publicly traded?

Yes, ADMA Biologics Inc - Common Stock is publicly traded.

What exchange does ADMA Biologics Inc - Common Stock trade on?

ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for ADMA Biologics Inc - Common Stock?

The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market

What is the current price of ADMA Biologics Inc - Common Stock?

The current price of ADMA Biologics Inc - Common Stock is 9.025

When was ADMA Biologics Inc - Common Stock last traded?

The last trade of ADMA Biologics Inc - Common Stock was at 07/06/26 03:40 PM ET

What is the market capitalization of ADMA Biologics Inc - Common Stock?

The market capitalization of ADMA Biologics Inc - Common Stock is 1.77B

How many shares of ADMA Biologics Inc - Common Stock are outstanding?

ADMA Biologics Inc - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.